The balloon-expandable covered stent’s indication aligns with AIOD, which includes treating lesions at the aortic bifurcation.

Getinge said EU MDR certification highlights its dedication to providing safe, effective, high-quality products. With the European Union’s more stringent requirements, it also highlights the company’s commitment to regulatory standards. The company said all this combines with a focus on future expanded indications for use.